Oncolytics Biotech Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research

CALGARY, AB, May 18 /PRNewswire-FirstCall/ - Oncolytics
Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that a paper entitled
"Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus
Type 3 Dearing and Palliative...